Trials / Unknown
UnknownNCT05366244
An Observational Study in Patients With Mild to Moderate COVID-19
An Observational, Real World Study to Observe Disease Outcomes in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Shanghai Pudong Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to observe real-world disease progression in mild-moderate COVID-19 patients with at least one risk factor for serve COVID-19 illness or death.
Detailed description
Screening interested participants should sign the appropriate informed consent (ICF) prior to completion any study procedures. The investigator will review symptoms, risk factors, and other non-invasive inclusion and exclusion criteria. The following is the general sequence of events during the 28-day evaluation period: Completion of baseline procedures Participants were assessed for 28 days and completed all safety monitoring.
Conditions
Timeline
- Start date
- 2022-05-02
- Primary completion
- 2023-04-30
- Completion
- 2023-04-30
- First posted
- 2022-05-09
- Last updated
- 2022-05-19
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05366244. Inclusion in this directory is not an endorsement.